Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vaccines

  Free Subscription


Articles published in AIDS

Retrieve available abstracts of 26 articles:
HTML format



Single Articles


    July 2021
  1. RUDDY JA, Boyarsky BJ, Bailey JR, Karaba AH, et al
    Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.
    AIDS. 2021 Jul 8. pii: 00002030-900000000-96349.
    PubMed     Abstract available


    June 2021
  2. NDUATI EW, Gorman MJ, Sein Y, Hermanus T, et al
    Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccination.
    AIDS. 2021 Jun 10. pii: 00002030-900000000-96374.
    PubMed     Abstract available


    May 2021
  3. RUDDY JA, Boyarsky BJ, Werbel WA, Bailey JR, et al
    Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV.
    AIDS. 2021 May 14. pii: 00002030-900000000-96405.
    PubMed     Abstract available


  4. GOSENS KCM, van der Zee RP, van Heukelom MLS, Jongen VW, et al
    HPV vaccination to prevent recurrence of Anal Intraepithelial Neoplasia in HIV+ MSM: a randomised, placebo-controlled multicentre trial.
    AIDS. 2021 May 5. pii: 00002030-900000000-96413.
    PubMed     Abstract available


    April 2021
  5. PREININGER L, Kahal DA, Szabo S
    Hepatitis B vaccination response and safety in people living with HIV/AIDS receiving HepB-CpG series.
    AIDS. 2021;35:845-846.
    PubMed    


    October 2019
  6. MEZA G, Exposito A, Royo JL, Ruiz-Garcia C, et al
    Association of CR2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 Vaccine.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002401.
    PubMed     Abstract available


  7. BARRY PA, Deere JD, Yue Y, Chang WW, et al
    Cytomegalovirus (CMV)-Vectored vaccines for HIV and other pathogens.
    AIDS. 2019 Oct 10. doi: 10.1097/QAD.0000000000002396.
    PubMed    



  8. Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix): Erratum Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection: E
    AIDS. 2019;33:1957.
    PubMed    


    August 2019
  9. FLYNN PM, Abrams EJ
    Response to correspondence entitled: Perinatal HIV and response to vaccination.
    AIDS. 2019;33:1675-1677.
    PubMed    


  10. DAUBY N
    Perinatal HIV and response to vaccination.
    AIDS. 2019;33:1674-1675.
    PubMed    


  11. FRENCH M
    Antibody-mediated control of HIV-1 infection through an alternative pathway.
    AIDS. 2019 Aug 1. doi: 10.1097/QAD.0000000000002313.
    PubMed     Abstract available


    July 2019
  12. DELL'ACQUA R, Galli L, Poli A, Mastrangelo A, et al
    Viro-immunological outcomes after thirteen-valent pneumococcal vaccination in HIV-1 infected subjects on stable virological suppression.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002307.
    PubMed     Abstract available


  13. DURIER C, Desaint C, Lelievre JD, Silbermann B, et al
    Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials: a French cohort study.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002310.
    PubMed     Abstract available


    March 2019

  14. Impact of aging and HIV infection on serologic response to seasonal influenza vaccination: Erratum.
    AIDS. 2019;33:771.
    PubMed    


  15. MACHIELS JD, Braam EE, van Bentum P, van Vugt M, et al
    Vaccination with Fendrix of prior nonresponding patients with HIV has a high success rate.
    AIDS. 2019;33:503-507.
    PubMed     Abstract available


  16. PANNUS P, Adams P, Willems E, Heyndrickx L, et al
    In-vitro viral suppressive capacity correlates with immune checkpoint marker expression on peripheral CD8+ T cells in treated HIV-positive patients.
    AIDS. 2019;33:387-398.
    PubMed     Abstract available


    October 2018
  17. PALICH R, Ghosn J, Chaillon A, Boilet V, et al
    Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial.
    AIDS. 2018 Oct 15. doi: 10.1097/QAD.0000000000002058.
    PubMed     Abstract available


  18. LEAL L, Guardo AC, Moron-Lopez S, Salgado M, et al
    Phase I clinical trial of an intranodally administered mRNA based therapeutic vaccine against HIV-1 infection.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002026.
    PubMed     Abstract available


    September 2018
  19. LUO Z, Ogunrinde E, Li M, Zhang L, et al
    Increased influenza-specific antibody avidity in HIV-infected females compared to HIV-infected males on antiretroviral therapy.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002022.
    PubMed     Abstract available


    August 2018
  20. COLIN DE VERDIERE N, Durier C, Samri A, Meiffredy V, et al
    Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients: ANRS EP46 NOVAA.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001963.
    PubMed     Abstract available


    May 2018
  21. WINCKELMANN A, Morcilla V, Shao W, Schleimann MH, et al
    Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1 infected individuals.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001861.
    PubMed     Abstract available


    April 2018
  22. GEORGE VK, Pallikkuth S, Pahwa R, de Armas L, et al
    Circulating inflammatory monocytes contribute to impaired influenza vaccine responses in HIV-infected participants.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001821.
    PubMed     Abstract available


    March 2018
  23. ISMAIL MF, Wong DK, Bogoch II
    The role for hepatitis A vaccination in HIV pre-exposure prophylaxis.
    AIDS. 2018;32:675-676.
    PubMed    


    February 2018
  24. FARFOUR E, Lesprit P, Wai ACH, Mazaux L, et al
    Acute hepatitis A breakthrough in MSM in Paris area: implementation of targeted hepatitis A virus vaccine in a context of vaccine shortage.
    AIDS. 2018;32:531-532.
    PubMed    


  25. PALLIKKUTH S, De Armas LR, Pahwa R, Rinaldi S, et al
    Impact of aging and HIV infection on serologic response to seasonal influenza vaccination.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001774.
    PubMed     Abstract available


  26. WEINBERG A, Huang S, Moscicki AB, Saah A, et al
    Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001773.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: